Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New online program shows promise in preventing teen emotional disorders

NCT ID NCT06350760

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an online program called PROCARE-I+ designed to prevent anxiety and depression in teenagers who are at high risk. Thirty adolescents with early symptoms took part in the program, which included extra modules tailored to their needs. Results showed improvements in their emotional state, quality of life, and ability to manage emotions. However, the study was small and had no comparison group, so more research is needed.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
online behavioral intervention (PROCARE-I+ program with add-on modules)
What this could lead to
If successful, this could provide an effective online tool to prevent anxiety and depression in at-risk teenagers, improving their emotional health and quality of life.
What could go wrong
This was a small, early-stage study with only 30 participants and no control group, so results may not apply to everyone. The program may not work for all teens or in different settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

139 people

The number who actually took part.

Started

Mar 2023

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 18 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * written informed consent from adolescent and legal guardian * able to attend prevention modules on his/her own * language competence * Strengths and Difficulties Questionnaire ""probable diagnoses" * score above cut-off for Revised Child Anxiety and Depression Scale-30 * having incipient symptoms on an emotional level in ADIS 5 C/P * absence of anxiety and/or mood disorders Exclusion Criteria: * in- or outpatient * concomitant psychological/psychiatric treatment * acute suicidality * general medical contraindications that hamper attendance to prevention modules * have been diagnosed with a neurodevelopmental disorder * Strengths and Difficulties Questionnaire "unlikely" or "possible diagnoses" * presence of mood and/or anxiety disorders

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety disorders and symptoms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Universidad Miguel Hernández

    Elche, Alicante, 03202, Spain

  • Universitat Rovira i Virgili

    Tarragona, Tarragona, 43003, Spain

  • University of Jaén

    Jaén, Jaen, 23071, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.